Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$768,197,412
+$110,669,052 QoQ
Shares Held
1,546,509
+5.0% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#30
of 1,735 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. VRTX ranks #1 (31.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $768,197,412 | 1,546,509 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $657,528,360 | 1,472,496 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $591,254,427 | 1,304,161 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $438,233,799 | 1,118,971 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $504,512,210 | 1,133,226 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,502,393,658 | 3,098,869 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,321,341,245 | 3,281,205 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,748,345,463 | 3,759,236 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,642,422,522 | 3,504,059 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,497,764,513 | 3,583,083 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,105,974,617 | 2,718,117 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $675,805,211 | 1,943,421 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $579,187,895 | 1,645,841 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $642,401,885 | 2,038,918 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $615,158,280 | 2,130,197 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $528,503,725 | 1,825,322 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $262,455,535 | 931,387 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $154,624,196 | 592,498 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $180,896,373 | 823,754 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,140,597 | 689,898 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $135,843,365 | 673,726 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||